Previous close | 4.9100 |
Open | 5.0500 |
Bid | 4.8300 x 200 |
Ask | 4.8800 x 200 |
Day's range | 4.8500 - 5.2400 |
52-week range | 1.8650 - 40.5800 |
Volume | |
Avg. volume | 4,024,972 |
Market cap | 346.151M |
Beta (5Y monthly) | 0.27 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Ventyx Biosciences (VTYX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Raju Mohan, CEO and President of Ventyx Biosciences Inc, executed a sale of 58,860 shares in the company on December 20, 2023, according to a recent SEC Filing.